These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11234344)

  • 1. A simple method for the identification and assay of iopamidol and iothalamate meglumine in pharmaceutical samples based on proton nuclear magnetic resonance spectroscopy.
    Hanna GM; Lau-Cam CA
    Pharmazie; 2001 Feb; 56(2):152-5. PubMed ID: 11234344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple 1H NMR spectroscopic method for assay of salts of the contrast agent diatrizoate in commercial solutions.
    Hanna GM; Lau-Cam CA
    J AOAC Int; 1996; 79(4):833-8. PubMed ID: 8757438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A stability-indicating proton nuclear magnetic resonance spectroscopic method for the analysis of propantheline bromide in pharmaceutical samples.
    Hanna GM; Lau-Cam CA
    Pharmazie; 2001 Sep; 56(9):700-3. PubMed ID: 11593989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton magnetic spectroscopic (PMR) determination of diphenhydramine hydrochloride in dosage forms.
    Hanna GM; Lau-Cam CA
    Pharmazie; 1984 Dec; 39(12):816-8. PubMed ID: 6531389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of platelet function by contrast media: iopamidol and ioxaglate versus iothalamate. Work in progress.
    Rao AK; Rao VM; Willis J; Beckett C; Steiner RM
    Radiology; 1985 Aug; 156(2):311-3. PubMed ID: 4011893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of ionic and nonionic contrast media on the sickling phenomenon.
    Rao VM; Rao AK; Steiner RM; Burka ER; Grainger RG; Ballas SK
    Radiology; 1982 Jul; 144(2):291-3. PubMed ID: 7089282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative neurotoxicity of angiographic contrast media.
    Velaj R; Drayer B; Albright R; Fram E
    Neurology; 1985 Sep; 35(9):1290-8. PubMed ID: 3927186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of contrast media in cerebral angiography: iopamidol vs. methylglucamine iothalamate.
    Bird CR; Drayer BP; Velaj R; Triolo PJ; Allen S; Bates M; Yeates AE; Heinz ER; Osborne DR
    AJNR Am J Neuroradiol; 1984; 5(6):801-3. PubMed ID: 6437183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of blood-brain barrier disruption by intracarotid iopamidol and methylglucamine iothalamate.
    Sage MR; Wilcox J; Evill CA; Benness GT
    AJNR Am J Neuroradiol; 1983; 4(4):893-5. PubMed ID: 6410875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of serotonin from human platelets in vitro by radiographic contrast media.
    Ring J; Sovak M
    Invest Radiol; 1981; 16(3):245-8. PubMed ID: 7053228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salutary effects of radiopaque contrast media on the survival of random-pattern skin flaps in the rat: an experimental study.
    Askar I; Bozkurt M; Oktay MF; Gürlek A; Keles C
    Microsurgery; 2004; 24(1):81-4. PubMed ID: 14748032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of blood-brain barrier disruption in the rabbit following intracarotid iopamidol and methylglucamine iothalamate.
    Wycherley AG; Wilcox J; Sage MR
    Australas Radiol; 1984 Nov; 28(4):294-6. PubMed ID: 6535564
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatic dynamic sequential CT: section enhancement profiles with a bolus of ionic and nonionic contrast agents.
    Nelson RC; Moyers JH; Chezmar JL; Hoel MJ; Jones EC; Peterson JE; Cork RD; Bernardino ME
    Radiology; 1991 Feb; 178(2):499-502. PubMed ID: 1987614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contrast medium resorption in ERCP].
    Carstensen F; Wurbs D
    Z Gastroenterol; 1993 Jun; 31(6):369-75. PubMed ID: 8212753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative determination of chlorpromazine. HCl in tablets, spansules, injectables, and bulk chemical by nuclear magnetic resonance spectroscopy.
    Zarembo JE; Warren RJ; Staiger DB
    J Assoc Off Anal Chem; 1978 Jan; 61(1):52-4. PubMed ID: 621193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple spectrophotometric procedure for the determination of various chontrast media in plasma.
    Medzihradsky F; Dahlstrom PJ; Hunter TB; Thornbury JR; Silver TM
    Invest Radiol; 1975; 10(5):532-5. PubMed ID: 1205713
    [No Abstract]   [Full Text] [Related]  

  • 17. 19F NMR as a powerful technique for the assay of anti-psychotic drug haloperidol in human serum and pharmaceutical formulations.
    Shamsipur M; Shafiee-Dastgerdi L; Talebpour Z; Haghgoo S
    J Pharm Biomed Anal; 2007 Feb; 43(3):1116-21. PubMed ID: 17084055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is contrast CT in acute pancreatitis harmful?].
    Rünzi M; Layer P
    Z Gastroenterol; 1995 Sep; 33(9):553-4. PubMed ID: 8525662
    [No Abstract]   [Full Text] [Related]  

  • 19. Measurement of plasma contrast levels during excretory urography.
    Hunter TB; Thornbury JR; Silver TM; Medzihradsky F
    Invest Urol; 1977 Mar; 14(5):378-9. PubMed ID: 845001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton magnetic resonance spectroscopic determination of bethanechol chloride in tablets.
    Hanna GM; Lau-Cam CA
    J Assoc Off Anal Chem; 1987; 70(3):557-9. PubMed ID: 2886488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.